TROUGH INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES IN SPONDYLOARTHRITIS PATIENTS ON TREATMENT WITH LOW DOSE INFLIXIMAB: A SINGLE CENTRE CROSS-SECTIONAL STUDY

被引：0
|
作者：
Patil, A. [1 ]
Upadhyaya, S. K. [1 ]
Dawar, R. [2 ]
Vaishnav, B. [1 ]
Dadhaniya, N. [1 ]
Gupta, S. J. [1 ]
Handa, R. [1 ]
机构：
[1] Indraprastha Apollo Hosp, Rheumatol, Delhi, India
[2] Indraprastha Apollo Hosp, Microbiol, Delhi, India
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.2690
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0683
引用
收藏
页码：1292 / 1292
页数：1
相关论文
共 50 条
  • [21] Letter: detection of infliximab levels and anti-infliximab antibodies comparison of three different assays
    Parussini, E.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (02) : 281 - 281
  • [22] Anti-infliximab antibodies in patients with an infusion related allergic response to infliximab.
    Wolbink, G
    de Groot, E
    Lems, W
    Dijkmans, B
    Nurmohamed, M
    Tak, PP
    Voskuyl, A
    Aarden, L
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S326 - S326
  • [23] Smoking is associated with low trough serum infliximab levels and presence of anti-infliximab antibody in maintenance treatment of inflammatory bowel disease (IBD)
    Kong, J. Y.
    Bundell, C. S.
    Pawlik, J.
    Hollingsworth, P. N.
    Forbes, G. M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 59 - 59
  • [24] The Monitoring of Infliximab Levels at Early Stages Can Predict the Development of Anti-Infliximab Antibodies in a Cohort of Rheumatoid Arthritis Patients Treated with Infliximab
    Plasencia-Rodriguez, Chamaida
    Pascual-Salcedo, Dora
    Gema Bonilla, Maria
    Villalba, Alejandro
    Peiteado, Diana
    Nuno, Laura
    Aguado, Pilar
    Jurado, Teresa
    Martin-Mola, Emilio
    Balsa, Alejandro
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1098 - S1098
  • [25] Monitoring of infliximab trough levels and anti-infliximab antibodies in inflammatory bowel diseases: A comparison of three commercially available ELISA kits
    Bertin, Daniel
    Serrero, Melanie
    Grimaud, Jean Charles
    Desjeux, Ariadne
    Desplat-Jego, Sophie
    CYTOKINE, 2020, 126
  • [26] LOSS OF RESPONSE IN IBD PATIENTS ON INFLIXIMAB TREATMENT: ASSAY OF TROUGH LEVELS AND TOTAL ANTIBODIES TO INFLIXIMAB
    Marzo, M.
    Armuzzi, A.
    Tolusso, B.
    Pugliese, D.
    Felice, C.
    Andrisani, G.
    Landi, R.
    Canestri, S.
    Gremese, E.
    Papa, A.
    Rapaccini, G.
    Guidi, L.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E177 - E177
  • [27] Trough serum infliximab level, anti-infliximab antibody status and response to infliximab maintenance treatment in inflammatory bowel disease (IBD)
    Kong, J. Y.
    Bundell, C. S.
    Pawlik, J.
    Hollingsworth, P. N.
    Forbes, G. M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 59 - 60
  • [28] ISOTYPE CHARACTERIZATION OF ANTI-INFLIXIMAB ANTIBODIES IN PEDIATRIC PATIENTS WITH RHEUMATIC DISEASES TREATED WITH INFLIXIMAB
    Kosmac, M.
    Toplak, N.
    Simonini, G.
    Cimaz, R.
    Serbec, V. Curin
    Avcin, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 255 - 255
  • [29] INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES COMPARISON BETWEEN TWO COMERCIAL ELISA VERSIONS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Hernandez Florez, D.
    Valor, L.
    Nieto, J. C.
    Martinez, L.
    de la Torre, I.
    del Rio, T.
    Gonzalez, C.
    Lopez-Longo, J.
    Monteagudo, I.
    Naredo, E.
    Montoro, M.
    Carreno Perez, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 715 - 716
  • [30] Infliximab trough levels among patients with inflammatory bowel disease in correlation with infliximab treatment escalation: a cross-sectional study from a Greek tertiary center
    Orfanidou, Afroditi
    Katsanos, Konstantinos
    Voulgaris, Theodoros
    Kofinas, Aristeidis
    Christodoulou, Maria Veatriki
    Konstandi, Maria
    Christodoulou, Dimitrios
    ANNALS OF GASTROENTEROLOGY, 2024, 37 (06):
12345